SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

OnKure Therapeutics, Inc. (OKUR) (CIK 0001637715) (OKUR)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
2.5 / 10
Correspondence-letter component
1.0
AI sentiment component
1.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 30, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Apr. 30, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 30, 2026 CORRESP Neutral/Informational Moderate OnKure Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by May 4, 2026… Read Filing EDGAR
Apr. 30, 2026 UPLOAD Concern from SEC Moderate On April 30, 2026, the SEC informed Nicholas A. Saccomano, CEO of OnKure Therapeutics, Inc., that they will not review the company's registration statement filed on April 24, 2026… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.